Clinical Trials Directory

Trials / Completed

CompletedNCT00987441

Epidural Labor Analgesia and Infant Neurobehavior

Epidural Analgesia for Labor Pain and Infant Neurobehavior

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,200 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
Female
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Infant neurobehavior alteration is predictor of later intelligence development. Many factors would influence or are associated with infant neurobehavior, of which exist or appear during perinatal period. Neuraxial, especially epidural, analgesia to date is the most effective method in relieving labor pain. Although previous studies showed that opioid used in epidural analgesia for labor pain can affect newborn neurobehavior negatively in a dose-escalation associated manner, whether epidural analgesia itself would produce unpredictable effect on newborn neurobehavior is still unknown. Hereby the investigators designed this trial to investigate the hypothesis that epidural analgesia for labor pain control itself would not produce negative effect on infant neurobehavior.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine and sufentanilRopivacaine 0.125% plus sufentanil 0.3 microgram
DRUGRopivacaine and sufentanilRopivacaine 0.125% plus sufentanil 0.4 microgram
DRUGRopivacaine and sufentanilRopivacaine 0.125% plus sufentanil 0.5 microgram
DRUGRopivacaine and sufentanilRopivacaine 0.0625% plus sufentanil 0.4 microgram
DRUGRopivacaine and sufentanilRopivacaine 0.1875% plus sufentanil 0.4 microgram
DRUGRopivacaine and sufentanilRopivacaine 0.25% plus sufentanil 0.4 microgram

Timeline

Start date
2009-09-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2009-10-01
Last updated
2011-07-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00987441. Inclusion in this directory is not an endorsement.